The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.
The top five companies covered are Amgen, AbbVie Inc., Johnson & Johnson, Bristol-Myers Squibb Company and Pfizer Inc. Amgen was the largest company in the biologics market in 2017.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The global biologics market was valued at around $221 billion in 2017. North America was the largest region in the biologics market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for more than 27% market share.
Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease that have limited treatment options. There has been a significant advancement for the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs.
The biologics market is segmented into Monoclonal Antibodies (MAbS), Vaccines and Recombinant Hormones/Proteins.
Monoclonal Antibodies (MAbS) are cells derived by cell division from a single ancestral cell. Monoclonal antibodies recognize and bind to antigens in order to discriminate between specific epitopes which provide protection against disease organisms.
Vaccines are biological preparations that provide immunity from a disease. Vaccines can be administered orally, through injections or by aerosol. Vaccines for cancers include both prophylactic vaccines and therapeutic vaccines.
Recombinant Hormones/Proteins are synthetic hormones secreted into the blood cycle to stimulate specific cells or tissues into action.